Isoflavone Completed Phase 2 Trials for Atrophy Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01553773Postmenopausal Facial Skin After Estradiol and Genistein Topical Treatment